Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 177
Filter
1.
Int. j. morphol ; 40(3): 697-705, jun. 2022. ilus, tab
Article in English | LILACS | ID: biblio-1385688

ABSTRACT

SUMMARY: An association between certain food additives and chronic diseases is reported. Current study determined whether administering toxic doses of the food additive monosodium glutamate (MSG) into rats can induce aortopathy in association with the oxidative stress and inflammatory biomarkers upregulation and whether the effects of MSG overdose can be inhibited by vitamin E. MSG at a dose of (4 mg/kg; orally) that exceeds the average human daily consumption by 1000x was administered daily for 7 days to the rats in the model group. Whereas, rats treated with vitamin E were divided into two groups and given daily doses of MSG plus 100 mg/ kg vitamin E or MSG plus 300 mg/kg vitamin E. On the eighth day, all rats were culled. Using light and electron microscopy examinations, a profound aortic injury in the model group was observed demonstrated by damaged endothelial layer, degenerated smooth muscle cells (SMC) with vacuoles and condensed nuclei, vacuolated cytoplasm, disrupted plasma membrane, interrupted internal elastic lamina, clumped chromatin, and damaged actin and myosin filaments. Vitamin E significantly protected aorta tissue and cells as well as inhibited MSG-induced tissue malondialdehyde (MDA), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). The highest used vitamin E dosage was more effective. Additionally, a significant correlation was observed between the aortic injury degree and tissue MDA, TNF-α, IL-6, and superoxide dismutase (SOD) levels (p=0.001). Vitamin E effectively protects against aortopathy induced by toxic doses of MSG in rats and inhibits oxidative stress and inflammation.


RESUMEN: Se reporta una asociación entre ciertos aditivos alimentarios y enfermedades crónicas. El objetivo de este estudio fue determinar si la administración de dosis tóxicas del aditivo alimentario glutamato monosódico (MSG) en ratas puede inducir aortopatía en asociación con el estrés oxidativo y la regulación positiva de los biomarcadores inflamatorios y si el efecto de una sobredosis de MSG se puede inhibir con vitamina E. Se administró MSG diariamente durante 7 días una dosis de (4 g/kg; por vía oral) que excede el consumo diario humano promedio, en 1000x a las ratas del grupo modelo. Mientras que las ratas tratadas con vitamina E se dividieron en dos grupos y se administraron dosis diarias de MSG más 100 mg/kg de vitamina E o MSG más 300 mg/kg de vitamina E. Todas las ratas fueron sacrificadas en el octavo día. Usando exámenes de microscopía óptica y electrónica, se observó una lesión aórtica profunda en el grupo modelo demostrada por una capa endotelial dañada, células musculares lisas degeneradas (SMC) con vacuolas y núcleos condensados, citoplasma vacuolado, membrana plasmática rota, lámina elástica interna interrumpida, cromatina agrupada y filamentos de actina y miosina dañados. La vitamina E protegió significativamente el tejido y las células de la aorta, además de inhibir el malondialdehído tisular (MDA) inducido por MSG, la interleucina-6 (IL-6) y el factor de necrosis tumoral alfa (TNF-α). La dosis más alta de vitamina E utilizada fue más efectiva. Además, se observó una correlación significativa entre el grado de lesión aórtica y los niveles tisulares de MDA, TNF-α, IL-6 y superóxido dismutasa (SOD) (p=0,001). La vitamina E efectivamente protege contra la aortopatía inducida por dosis tóxicas de MSG en ratas e inhibe el estrés oxidativo y la inflamación.


Subject(s)
Animals , Rats , Aorta/drug effects , Aortic Diseases/chemically induced , Sodium Glutamate/toxicity , Vitamin E/pharmacology , Aorta/pathology , Sodium Glutamate/administration & dosage , Vitamin E/administration & dosage , Microscopy, Electron , Interleukin-6/antagonists & inhibitors , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Rats, Sprague-Dawley , Oxidative Stress/drug effects , Disease Models, Animal , Malondialdehyde/antagonists & inhibitors
2.
Molecules ; 26(15)2021 Jul 30.
Article in English | MEDLINE | ID: mdl-34361786

ABSTRACT

Silver birch, Betula pendula Roth, is one of the most common trees in Europe. Due to its content of many biologically active substances, it has long been used in medicine and cosmetics, unlike the rare black birch, Betula obscura Kotula. The aim of the study was therefore to compare the antioxidant properties of extracts from the inner and outer bark layers of both birch trees towards the L929 line treated with acetaldehyde. Based on the lactate dehydrogenase test and the MTT test, 10 and 25% concentrations of extracts were selected for the antioxidant evaluation. All extracts at tested concentrations reduced the production of hydrogen peroxide, superoxide anion radical, and 25% extract decreased malonic aldehyde formation in acetaldehyde-treated cells. The chemical composition of bark extracts was accessed by IR and HPLC-PDA methods and surprisingly, revealed a high content of betulin and lupeol in the inner bark extract of B. obscura. Furthermore, IR analysis revealed differences in the chemical composition of the outer bark between black and silver birch extracts, indicating that black birch may be a valuable source of numerous biologically active substances. Further experiments are required to evaluate their potential against neuroinflammation, cancer, viral infections, as well as their usefulness in cosmetology.


Subject(s)
Antioxidants/pharmacology , Betula/chemistry , Plant Bark/chemistry , Plant Extracts/pharmacology , Acetaldehyde/antagonists & inhibitors , Acetaldehyde/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Betula/classification , Cell Line , Chromatography, High Pressure Liquid , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Hydrogen Peroxide/antagonists & inhibitors , Malondialdehyde/antagonists & inhibitors , Mice , Oxidants/antagonists & inhibitors , Oxidants/pharmacology , Pentacyclic Triterpenes/chemistry , Pentacyclic Triterpenes/isolation & purification , Plant Bark/classification , Plant Extracts/chemistry , Poland , Superoxides/antagonists & inhibitors , Triterpenes/chemistry , Triterpenes/isolation & purification
3.
Drug Deliv ; 28(1): 1363-1375, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34180761

ABSTRACT

Targeted treatment of cerebral ischemia/reperfusion injury (CIRI) remains a problem due to the difficulty in drug delivery across the blood-brain barrier (BBB). In this study, we developed Bo-TSA-NP, a novel tanshinone IIA (TSA) loaded nanoparticles modified by borneol, which has long been proved with the ability to enhance other drugs' transport across the BBB. The Bo-TSA-NP, with a particle size of about 160 nm, drug loading of 3.6%, showed sustained release and P-glycoprotein (P-gp) inhibition property. It demonstrated a significantly higher uptake by 16HBE cells in vitro through the clathrin/caveolae-mediated endocytosis and micropinocytosis. Following intranasal (IN) administration, Bo-TSA-NP significantly improved the preventive effect on a rat model of CIRI with improved neurological scores, decreased cerebral infarction areas and a reduced content of malondialdehyde (MDA) and increased activity of superoxide dismutase (SOD) in rat brain. In conclusion, these results indicate that Bo-TSA-NP is a promising nose-to-brain delivery system that can enhance the prevention effect of TSA on CIRI.


Subject(s)
Abietanes/pharmacology , Brain Ischemia/drug therapy , Camphanes/chemistry , Nanoparticles/chemistry , Neuroprotective Agents/pharmacology , Reperfusion Injury/prevention & control , ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors , Adjuvants, Pharmaceutic , Administration, Intranasal , Animals , Brain/drug effects , Chemistry, Pharmaceutical , Delayed-Action Preparations , Disease Models, Animal , Drug Carriers , Malondialdehyde/antagonists & inhibitors , Particle Size , Polyethylene Glycols/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Rats , Succinimides/chemistry , Superoxide Dismutase/biosynthesis
4.
Biosci Biotechnol Biochem ; 85(5): 1183-1193, 2021 Apr 24.
Article in English | MEDLINE | ID: mdl-33704405

ABSTRACT

Obesity is one of the most critical risk factors for diabetes mellitus and plays a significant role in diabetic nephropathy (DN). The present investigation aimed to evaluate the possible mechanism of action of vitexin on obesity-induced DN in a high-fat diet (HFD)-fed experimental C57BL/6 mice model. Obesity was induced in male C57BL/6 mice by chronic administration of HFD, and mice were concomitantly treated with vitexin (15, 30, and 60 mg/kg, p.o.). HFD-induced increased renal oxido-nitrosative stress and proinflammatory cytokine levels were significantly inhibited by vitexin. The Western blot analysis suggested that alteration in renal NF-κB, IκBα, nephrin, AMPK, and ACC phosphorylation levels was effectively restored by vitexin treatment. Histological aberration induced in renal tissue after chronic administration of HFD was also reduced by vitexin. In conclusion, vitexin suppressed the progression of obesity-induced DN via modulation of NF-κB/IkBα and AMPK/ACC pathways in an experimental model of HFD-induced DN in C57BL/6J mice.


Subject(s)
Anti-Obesity Agents/pharmacology , Apigenin/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/drug therapy , Hypoglycemic Agents/pharmacology , Obesity/drug therapy , AMP-Activated Protein Kinases/genetics , AMP-Activated Protein Kinases/metabolism , Acetyl-CoA Carboxylase/genetics , Acetyl-CoA Carboxylase/metabolism , Animals , Anti-Obesity Agents/isolation & purification , Apigenin/isolation & purification , Diabetes Mellitus, Experimental/etiology , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/pathology , Diabetic Nephropathies/etiology , Diabetic Nephropathies/genetics , Diabetic Nephropathies/pathology , Diet, High-Fat/adverse effects , Gene Expression Regulation , Hypoglycemic Agents/isolation & purification , I-kappa B Kinase/genetics , I-kappa B Kinase/metabolism , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mice , Mice, Inbred C57BL , NF-kappa B/genetics , NF-kappa B/metabolism , Obesity/etiology , Obesity/genetics , Obesity/pathology , Plant Extracts/chemistry , Signal Transduction , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Trigonella/chemistry , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
5.
Carbohydr Polym ; 256: 117516, 2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33483037

ABSTRACT

A novel polysaccharide (MFP1P) was isolated from Fructus Mori, followed by purification via DEAE-52 cellulose and 27 % ethanol fraction. The MFP1P had the molecular weight of 56.78 kDa and the total sugar content of 93.32±0.54 %. And the MFP1P is mainly composed of glucose, galactose, galacturonic acid and mannose with molar ratio of 66.62 %, 13.94 %, 18.24 % and 1.20 %, respectively. MFP1P was mainly composed of →3)-α-D-Gal (1→, ß-D-Man-(1→ and →6)-α-D-Glc (1→ glycosidic bond and showed a spherical chain conformation with uniform distribution in solution. The MFP1P exhibited great antioxidant activity with oxygen-free radical absorption capacity (ORAC) values of 291.63±6.81 µmol TE/g and MDA IC50 of 0.289±0.022 mg/mL.


Subject(s)
Antioxidants/chemistry , Fruit/chemistry , Liver/drug effects , Morus/chemistry , Oxidants/antagonists & inhibitors , Polysaccharides/chemistry , Amidines/antagonists & inhibitors , Amidines/chemistry , Animals , Antioxidants/isolation & purification , Antioxidants/pharmacology , Carbohydrate Sequence , Chemical Fractionation/methods , Complex Mixtures/chemistry , Galactose/chemistry , Galactose/isolation & purification , Glucose/chemistry , Glucose/isolation & purification , Hexuronic Acids/chemistry , Hexuronic Acids/isolation & purification , Liver/metabolism , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mannose/chemistry , Mannose/isolation & purification , Mice , Molecular Weight , Oxidants/chemistry , Plant Extracts/chemistry , Polysaccharides/isolation & purification , Polysaccharides/pharmacology
6.
Biomolecules ; 10(12)2020 12 09.
Article in English | MEDLINE | ID: mdl-33317112

ABSTRACT

Detoxification is one of the main vital tasks performed by the liver. The purpose of this study was to investigate whether mustard in its normal or nanoparticles could confer a protective/therapeutic effect against TAA-induced acute liver failure in experimental animal models. Mustard ethanolic extract was analyzed by HPLC/MS. To induce liver failure, male rats were injected with 350 mg/kg bw TAA IP, then treated orally with a dose of 100 mg/kg for 15 d of mustard extract and its nanoform before and following induction. The levels of serum liver functions, total cholesterol (TCHo), total glyceride (TG), total bilirubin (TBIL), hepatic malonaldhyde (MDA) and nitric oxide (NO),glutathione (GSH), sodium oxide dismutase (SOD), as well as tumor necrosis factor (TNF-α,) and interleukin 6 (IL-6), were estimated. DNA genotoxicity and hepatic pathology, and immunohistologic (IHC) changes were assayed. The antioxidant content of Phenolic acids, flavonoids in mustard ethanolic extract substantially decreased the levels of ALT, AST, ALP and rehabilitated the histopathological alterations. In addition, nanoforms of mustard ethanol extract have notably increased the levels of GSH, SOD and significantly reduced the levels of MDA. The expression levels of TNF-α and IL-6 in serum and tissue were markedly downregulated. DNA genotoxicity was significantly reversed. Mustard introduced a protective and medicinal effect against TAA in both its forms.


Subject(s)
Antioxidants/pharmacology , Chemical and Drug Induced Liver Injury/prevention & control , Metal Nanoparticles/administration & dosage , Mustard Plant/chemistry , Silver/pharmacology , Administration, Oral , Animals , Antioxidants/chemistry , Bilirubin/blood , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Cholesterol/blood , DNA Damage , Drug Administration Schedule , Glutathione/agonists , Glutathione/metabolism , Interleukin-6/antagonists & inhibitors , Interleukin-6/genetics , Interleukin-6/metabolism , Liver/drug effects , Liver/metabolism , Liver/pathology , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Metal Nanoparticles/chemistry , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Plant Extracts/chemistry , Rats , Rats, Wistar , Silver/chemistry , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Thioacetamide/administration & dosage , Thioacetamide/antagonists & inhibitors , Triglycerides/blood , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
7.
Acta Biochim Pol ; 67(4): 521-529, 2020 Dec 17.
Article in English | MEDLINE | ID: mdl-33332077

ABSTRACT

This study aims to investigate the protection of dexmedetomidine (Dex) against pulmonary ischemia-reperfusion injury (PIRI) in the mouse model and reveal the mechanism in hypoxia reoxygenation (H/R)-induced mouse pulmonary vascular endothelial cells (MPVECs). The lung wet-to-dry weight ratio, histopathological features, and malondialdehyde (MDA) concentrations were measured. The H/R-induced MPVECs were exposed to Dex, and the cell viability, cell apoptosis and protein expressions were assessed by the Cell Counting Kit-8 (CCK8) assay, flow cytometry and western blot, respectively. In addition, the regulatory relationship between miR-21-5p and orphan nuclear receptor 4A1 (Nr4a1) was revealed by several assays, including the dual-luciferase reporter assay, real-time quantitative polymerase chain reaction (RT-qPCR) and western blot. We found that the Dex treatment significantly alleviated pulmonary injury and decreased the level of MDA and wet/dry weight ratio in PIRI mice. Dex treatment also increased cell viability, reduced apoptotic ratio and downregulated expression levels of Cleaved Caspase-3 and Cleaved Caspase-9 in H/R induced MPVECs. Furthermore, the expression of miR-21-5p was upregulated, while Nr4a1 was downregulated by Dex in a concentration-dependent manner in H/R induced MPVECs. Moreover, Nr4a1 was verified as a target of miR-497-5p. Overexpression of Nr4a1 could reverse the protective effects of Dex on alleviating H/R-induced injury in MPVECs. Taken together, Dex treatment attenuated ischemia-reperfusion induced pulmonary injury through modulating the miR-21-5p/Nr4a1 signaling pathway.


Subject(s)
Adrenergic alpha-2 Receptor Agonists/pharmacology , Dexmedetomidine/pharmacology , Endothelial Cells/drug effects , MicroRNAs/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Reperfusion Injury/drug therapy , Animals , Apoptosis/drug effects , Base Pairing , Base Sequence , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/genetics , Caspase 9/metabolism , Cell Survival/drug effects , Endothelial Cells/metabolism , Endothelial Cells/pathology , Female , Gene Expression Regulation , HEK293 Cells , Humans , Lung/drug effects , Lung/metabolism , Lung/pathology , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mice , Mice, Inbred C57BL , MicroRNAs/metabolism , Nuclear Receptor Subfamily 4, Group A, Member 1/antagonists & inhibitors , Nuclear Receptor Subfamily 4, Group A, Member 1/metabolism , Reperfusion Injury/genetics , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Signal Transduction
8.
Biomed Res Int ; 2020: 8260703, 2020.
Article in English | MEDLINE | ID: mdl-33134388

ABSTRACT

OBJECTIVE: To explore the effects of the Hedysarum multijugum Maxim.-Radix Salviae compound (Huangqi-Danshen Compound (HDC)) on oxidative capacity and cardiomyocyte apoptosis in rats with diabetic cardiomyopathy by a network pharmacology-based strategy. METHODS: Traditional Chinese Medicine (TCM)@Taiwan, TCM Systems Pharmacology Database and Analysis Platform (TCMSP), TCM Integrated Database (TCMID), and High-Performance Liquid Chromatography (HPLC) technology were used to obtain and screen HDC's active components, and the PharmMapper database was used to predict HDC human target protein targets. The DCM genes were collected from the GeneCards and OMIM databases, and the network was constructed and analyzed by Cytoscape 3.7.1 and the Database for Annotation, Visualization, and Integrated Discovery (DAVID). Finally, HDC was used to intervene in diabetic cardiomyopathy (DCM) model rats, and important biological processes and signaling pathways were verified using techniques such as immunohistochemistry. RESULTS: A total of 176 of HDC's active components and 442 potential targets were obtained. The results of network analysis show that HDC can regulate DCM-related biological processes (such as negative regulation of the apoptotic process, response to hypoxia, the steroid hormone-mediated signaling pathway, cellular iron ion homeostasis, and positive regulation of phosphatidylinositol 3-kinase signaling) and signaling pathways (such as the HIF-1 signaling pathway, the estrogen signaling pathway, insulin resistance, the PPAR signaling pathway, the VEGF signaling pathway, and the PI3K-Akt signaling pathway). Animal experiments show that HDC can reduce fasting plasma glucose (FPG), HbA1c, and malondialdehyde (MDA) and increase superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) (P < 0.05). The results of immunohistochemistry showed that HDC can regulate the protein expression of apoptosis-related signaling pathways in DCM rats (P < 0.05). CONCLUSION: It was initially revealed that HDC improves DCM through its antiapoptotic and anti-inflammatory effects. HDC may play a therapeutic role by improving cardiomyocyte apoptosis in DCM rats.


Subject(s)
Antioxidants/pharmacology , Cardiotonic Agents/pharmacology , Diabetic Cardiomyopathies/drug therapy , Drugs, Chinese Herbal/pharmacology , Myocytes, Cardiac/drug effects , Animals , Apoptosis/drug effects , Apoptosis/genetics , Astragalus propinquus , Blood Glucose/metabolism , Diabetic Cardiomyopathies/etiology , Diabetic Cardiomyopathies/genetics , Diabetic Cardiomyopathies/physiopathology , Diet, High-Fat/adverse effects , Dietary Sugars/adverse effects , Gene Expression Regulation/drug effects , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Glycated Hemoglobin/genetics , Glycated Hemoglobin/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Medicine, Chinese Traditional , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Oxidative Stress/drug effects , Peroxisome Proliferator-Activated Receptors/genetics , Peroxisome Proliferator-Activated Receptors/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Wistar , Salvia miltiorrhiza , Signal Transduction , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
9.
Carbohydr Polym ; 246: 116620, 2020 Oct 15.
Article in English | MEDLINE | ID: mdl-32747259

ABSTRACT

In this study, a water-soluble polysaccharide (BSP) was extracted and purified from pseudobulb of Bletilla striata. The preliminary structure and gastroprotective activity of BSP were analyzed. Results indicate that BSP is a glucomannan with a molar ratio of 7.45:2.55 (Man:Glc), and its molecular weight is approximately 1.7 × 105 Da. BSP displayed outstanding protective action against ethanol-induced GES-1 cell injury in vitro, as well as, excellent gastroprotective activity in vivo. Especially, a high-dose of BSP (100 mg/kg) could reduce the ulcer index of the gastric mucosa and increase the percentage of ulcer inhibition, which possibly caused by enhancing the antioxidant capacity and inhibiting the apoptotic pathway in gastric tissue. Interestingly, BSP exhibited a comparative gastroprotective activity to that of positive control (omeprazole). In summary, our results indicated that BSP could be considered as a potential supplement for the prevention of gastric injury.


Subject(s)
Antioxidants/pharmacology , Gastric Mucosa/drug effects , Gastrointestinal Agents/pharmacology , Mannans/pharmacology , Orchidaceae/chemistry , Stomach Ulcer/prevention & control , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Catalase/metabolism , Cell Line , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Ethanol/antagonists & inhibitors , Ethanol/toxicity , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Gastrointestinal Agents/chemistry , Gastrointestinal Agents/isolation & purification , Germ-Free Life , Glutathione Peroxidase/metabolism , Humans , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mannans/chemistry , Mannans/isolation & purification , Mice , Molecular Weight , Omeprazole/pharmacology , Solubility , Stomach Ulcer/chemically induced , Stomach Ulcer/metabolism , Stomach Ulcer/pathology , Superoxide Dismutase/metabolism , Water/chemistry
10.
Kaohsiung J Med Sci ; 36(9): 732-740, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32374939

ABSTRACT

Cisplatin, as one of the most effective chemotherapeutic agents, its clinical use is limited by serious side effect of nephrotoxicity. Cisplatin-induced nephrotoxicity is closely related to apoptosis induction and activation of caspase. The present study aimed to explore the potential protective effect of ginsenoside Rk1 (Rk1), a rare ginsenoside generated during steaming ginseng, on cisplatin-induced nephrotoxicity and the underlying mechanisms in human embryonic kidney 293 (HEK-293) cells. Our results showed that the reduced cell viability induced by cisplatin could significantly recover by Rk1. Furthermore, glutathione (GSH) as an oxidative index, was elevated and the lipid peroxidation product malondialdehyde (MDA) was significantly decreased after Rk1 treatment compared to the cisplatin group. Additionally, Rk1 can also decrease the ROS fluorescence expression and increase the protein levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) compared to the cisplatin group, which suggested a suppression of oxidative response. More importantly, the cisplatin-induced elevated protein levels of Bax, cleaved caspase-3, cleaved caspase-9, and decreased protein level of Bcl-2 were reversed after treatment with Rk1. Our results elucidated the possible protective mechanism of Rk1 for the first time, which may involve in its anti-oxidation and anti-apoptosis effects.


Subject(s)
Antineoplastic Agents/toxicity , Antioxidants/pharmacology , Cisplatin/toxicity , Gene Expression Regulation/drug effects , Ginsenosides/pharmacology , Antioxidants/isolation & purification , Caspase 3/genetics , Caspase 3/metabolism , Caspase 9/genetics , Caspase 9/metabolism , Cisplatin/antagonists & inhibitors , Ginsenosides/isolation & purification , Glutathione/agonists , HEK293 Cells , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Humans , Malondialdehyde/antagonists & inhibitors , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Oxidative Stress/drug effects , Panax/chemistry , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Signal Transduction , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism
11.
Life Sci ; 248: 117475, 2020 May 01.
Article in English | MEDLINE | ID: mdl-32119963

ABSTRACT

AIMS: Liver fibrosis is a crucial pathological feature which could result in cirrhosis and hepatocarcinoma. But until now, there is no favourable treatment for it. Apigenin (APG) is a flavonoid, which exhibits efficient anti-liver fibrosis activity, but its underlying mechanisms were rarely studied. So this work aims to estimate the potential therapeutic action of APG on liver fibrosis rats and to gain insight into its system-level mechanisms. MAIN METHODS: Hepatic fibrosis was induced by CCl4 in Wistar rats, and APG was given in the light of the regimen. Biochemical indexes, histopathological change and immunohistochemistry of liver were evaluated. The optimal effect group of APG was selected for further transcriptomic and proteomic analysis. KEY FINDINGS: APG ameliorated liver fibrosis via reducing the levels of AST, ALT, ALP, LDH, Hyp, TP, TB, DB, HA, LN, PCIII and IV-C, mitigating fibrosis and inflammation of liver in H&E and Masson staining. Mechanistically, APG elevated the activity of ALB, SOD and GSH-PX with reducing the level of MDA. The results of microarray and TMT revealed that 4919 genes and 4876 proteins were differentially expressed in the APG and model groups. Besides, transcriptomics and proteomics analyses unfolded 120 overlapped proteins, enriched in 111 GO terms containing apoptotic process, angiogenesis, cell migration and proliferation, etc. Meanwhile, KEGG pathway analysis showed that 26 pathways containing HIF-1/MAPK/eNOS/VEGF/PI3K/Akt signaling pathway, regulation of actin cytoskeleton and focal adhesion mostly. SIGNIFICANCE: APG can ameliorate CCl4-induced liver fibrosis via VEGF-mediated FAK phosphorylation through the MAPKs, PI3K/Akt, HIF-1, ROS, and eNOS pathways, which may hopefully become the anti-liver fibrosis activity of natural product.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Apigenin/pharmacology , Chemical and Drug Induced Liver Injury/prevention & control , Liver Cirrhosis/prevention & control , Liver/drug effects , Transcriptome/drug effects , Alanine Transaminase/genetics , Alanine Transaminase/metabolism , Albumins/metabolism , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Animals , Aspartate Aminotransferases/genetics , Aspartate Aminotransferases/metabolism , Bilirubin/blood , Carbon Tetrachloride/administration & dosage , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/genetics , Chemical and Drug Induced Liver Injury/pathology , Focal Adhesion Kinase 1/genetics , Focal Adhesion Kinase 1/metabolism , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/metabolism , Liver/metabolism , Liver/pathology , Liver Cirrhosis/chemically induced , Liver Cirrhosis/genetics , Liver Cirrhosis/pathology , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Nitric Oxide Synthase Type III/genetics , Nitric Oxide Synthase Type III/metabolism , Proteomics/methods , Rats , Rats, Wistar , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
12.
Fitoterapia ; 143: 104551, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32173421

ABSTRACT

Five new alkaloids (1-5), including three new aporphine alkaloids and two new phenanthrene alkaloids, together with 10 known compounds (6-15) were obtained from the roots of Stephania tetrandra. Their structures were elucidated by spectroscopic methods, single-crystal X-ray diffraction, and electronic circular dichroism analyses. Compounds 7-10, and 13 showed antioxidant activities with malondialdehyde (MDA) inhibitory rates of 62.50 ± 1.91 to 98.44 ± 0.34% at the concentration of 10 µM.


Subject(s)
Alkaloids/pharmacology , Antioxidants/pharmacology , Aporphines/pharmacology , Phenanthrenes/pharmacology , Stephania tetrandra/chemistry , Alkaloids/isolation & purification , Animals , Antioxidants/isolation & purification , Aporphines/isolation & purification , China , Circular Dichroism , Lipid Peroxidation , Malondialdehyde/antagonists & inhibitors , Microsomes, Liver/drug effects , Molecular Structure , Phenanthrenes/isolation & purification , Phytochemicals/isolation & purification , Phytochemicals/pharmacology , Plant Roots/chemistry , Rats
13.
Probiotics Antimicrob Proteins ; 12(4): 1459-1470, 2020 12.
Article in English | MEDLINE | ID: mdl-31970648

ABSTRACT

The aim of this study was to assess the protective effect of the intracellular content obtained from potential probiotic bacteria against acrylamide-induced oxidative damage in human erythrocytes. First, the antioxidant properties of 12 potential probiotic strains was evaluated. Two commercial probiotic bacteria were included as reference strains, namely, Lactobacillus casei Shirota and Lactobacillus paracasei 431. Data showed that the intracellular content from four strains, i.e., Lactobacillus fermentum J10, Lactobacillus pentosus J24 and J26, and Lactobacillus pentosus J27, showed higher (P < 0.05) antioxidant capacity in most methods used. Thereafter, the intracellular content of such pre-selected strains was able to prevent the disturbance of the antioxidant system of human erythrocytes exposed to acrylamide, thereby reducing cell disruption and eryptosis development (P < 0.05). Additionally, the degree of oxidative stress in erythrocytes exposed to acrylamide was significantly (P < 0.05) reduced to levels similar to the basal conditions when the intracellular content of Lact. fermentum J10, Lact. pentosus J27, and Lact. paracasei 431 were employed. Hence, our findings suggest that the intracellular contents of specific Lactobacillus strains represent a potential source of metabolites with antioxidant properties that may help reduce the oxidative stress induced by acrylamide in human erythrocytes.


Subject(s)
Acrylamide/pharmacology , Antioxidants/pharmacology , Complex Mixtures/pharmacology , Lacticaseibacillus casei/chemistry , Lacticaseibacillus paracasei/chemistry , Lactobacillus pentosus/chemistry , Limosilactobacillus fermentum/chemistry , Acrylamide/antagonists & inhibitors , Antioxidants/chemistry , Catalase/metabolism , Cells, Cultured , Chromans/pharmacology , Complex Mixtures/chemistry , Erythrocytes/cytology , Erythrocytes/drug effects , Erythrocytes/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Hemolysis/drug effects , Humans , Lacticaseibacillus casei/metabolism , Limosilactobacillus fermentum/metabolism , Lacticaseibacillus paracasei/metabolism , Lactobacillus pentosus/metabolism , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Oxidation-Reduction , Oxidative Stress , Probiotics/chemistry , Superoxide Dismutase/metabolism
14.
Life Sci ; 248: 116481, 2020 May 01.
Article in English | MEDLINE | ID: mdl-31102744

ABSTRACT

AIMS: Hypobaric hypoxia (HH), linked to oxidative stress, impairs cardiac function. We synthesized a novel nitronyl nitroxide radical, an HPN derivative (HEPN) and investigated the protective effects of HEPN and HPN against HH-induced heart injury in mice and the underlying mechanisms of action. MAIN METHODS: Mice were administered with HPN (200 mg/kg) or HEPN (200 mg/kg) 30 min before exposed to HH. The cardiac function was measured. Serum AST, CK, LDH and cTnI were estimated. Heart tissue oxidase activity, SOD, CAT, GSH-Px, ROS and MDA were estimated. ATP content, Na+/K+-ATPase and Ca2+/Mg2+-ATPase activity was measured. The expression of HIF-1, VEGF, Nrf2, HO-1, Bax, Bcl-2, Caspase-3 was estimated. KEY FINDINGS: Results showed that pretreatment with HEPN or HPN led to a dramatic decrease in the activity of biochemical markers AST, CK, LDH and cTnI in murine serum. They increased the activity of SOD, CAT and GSH-Px and reduced the level of ROS and MDA in the hearts of mice. HEPN and HPN could increase the expression of Nrf2 and OH-1. They could maintain the ATPase activity. The Bax and Caspase-3 expression as well as the ratio of Bax/Bcl-2 were significantly downregulated and the Bcl-2 expression was upregulated by HPN or HEPN compared to the HH group. They may attenuate the HH-induced oxidant stress via free radical scavenging activity. SIGNIFICANCE: The present study showed that the nitronyl nitroxide radical HEPN and HPN may be potential therapeutic agents for treatment of HH-induced cardiac dysfunction.


Subject(s)
Antioxidants/pharmacology , Cardiotonic Agents/pharmacology , Heart Failure/drug therapy , Hypoxia/drug therapy , Nitrogen Oxides/pharmacology , Animals , Antioxidants/chemical synthesis , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/genetics , Ca(2+) Mg(2+)-ATPase/genetics , Ca(2+) Mg(2+)-ATPase/metabolism , Cardiotonic Agents/chemical synthesis , Casein Kinases/blood , Casein Kinases/genetics , Caspase 3/genetics , Caspase 3/metabolism , Catalase/blood , Catalase/genetics , Gene Expression Regulation/drug effects , Glutathione Peroxidase/blood , Glutathione Peroxidase/genetics , Heart Failure/etiology , Heart Failure/genetics , Heart Failure/physiopathology , Heart Function Tests , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Hypoxia/complications , Hypoxia/genetics , Hypoxia/physiopathology , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , L-Lactate Dehydrogenase/blood , L-Lactate Dehydrogenase/genetics , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred BALB C , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Nitrogen Oxides/chemical synthesis , Oxidative Stress/drug effects , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Sodium-Potassium-Exchanging ATPase/genetics , Sodium-Potassium-Exchanging ATPase/metabolism , Superoxide Dismutase/blood , Superoxide Dismutase/genetics , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/metabolism
15.
Arch Physiol Biochem ; 126(1): 89-93, 2020 Feb.
Article in English | MEDLINE | ID: mdl-30081678

ABSTRACT

This study was conducted to determine the effect of astaxanthin (ASX) treatment on alleviation of renal damage in high fructose induced nephrotoxicity in rats. Treatments were arranged in a 2 × 2 factorial fashion: administrations of fructose (30%, via drinking water) and ASX (1 mg/kg/day, within 0.2 ml olive oil) for 8 weeks. Data were analyzed by two-way ANOVA. The ASX treatment decreased serum urea (p < .01) and blood urea-N concentrations (p < .02) at a lower extent in rats receiving fructose than those not receiving fructose. Moreover, the ASX treatment reversed the increases in malondialdehyde (MDA) (p < .0001) and nuclear factor kappa B (NF-κB) (p < .0003) levels and the decreases in superoxide dismutase (SOD) activity (p < .0001) and sirtuin-1 (SIRT1) level (p < .0004), in the kidney upon high fructose consumption. The data suggest that ASX supplementation alleviates renal damage induced by high fructose consumption through modulating NF-κB/SIRT1 pathway and mitigating oxidative stress.


Subject(s)
Antioxidants/pharmacology , Fructose/adverse effects , Kidney/drug effects , NF-kappa B/genetics , Sirtuin 1/genetics , Animals , Blood Urea Nitrogen , Diet/adverse effects , Gene Expression Regulation , Kidney/metabolism , Kidney/pathology , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/blood , NF-kappa B/metabolism , Oxidative Stress/drug effects , Rats , Rats, Wistar , Signal Transduction , Sirtuin 1/metabolism , Superoxide Dismutase/blood , Urea/antagonists & inhibitors , Urea/blood , Xanthophylls/pharmacology
16.
Arch Physiol Biochem ; 126(2): 95-100, 2020 May.
Article in English | MEDLINE | ID: mdl-30169970

ABSTRACT

This study investigated the effects of garlic on anxiety- and depression-related behaviors and brain oxidative markers in streptozotocin (STZ)-induced diabetes in rats. Fifty-six male Wistar rats were randomly divided into seven experimental groups (n = 8/group): control, diabetic + saline, diabetic + garlic, diabetic + imipramine, and diabetic + diazepam groups. Animals received garlic homogenate (0.1, 0.25, and 0.5 g/kg) for 10 days. At the end of the treatments, anxiety- and depressive-related behaviors were evaluated by elevated plus maze (EPM) and forced swimming test (FST), respectively. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities and malondialdehyde (MDA) levels were measured in the brain. Diabetic + garlic (0.5 g/kg) group showed lower anxiety- and- depressive-like behaviors as compared to the diabetic rats. Furthermore, garlic treatment (0.5 g/kg) attenuated MDA levels and enhanced SOD and GPx activities in the brain. Our findings indicate that garlic alleviates anxiety- and depression-related behaviors in the diabetic rats possibly by attenuation of brain oxidative stress.


Subject(s)
Antidepressive Agents/pharmacology , Antioxidants/pharmacology , Anxiety/prevention & control , Depressive Disorder/prevention & control , Garlic/chemistry , Plant Extracts/pharmacology , Stress, Psychological/prevention & control , Animals , Anxiety/complications , Anxiety/metabolism , Anxiety/physiopathology , Brain/drug effects , Brain/metabolism , Depressive Disorder/complications , Depressive Disorder/metabolism , Depressive Disorder/physiopathology , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diazepam/pharmacology , Glutathione Peroxidase/metabolism , Imipramine/pharmacology , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Maze Learning/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Streptozocin , Stress, Psychological/complications , Stress, Psychological/metabolism , Stress, Psychological/physiopathology , Superoxide Dismutase/metabolism , Swimming
17.
Arch Physiol Biochem ; 126(2): 107-115, 2020 May.
Article in English | MEDLINE | ID: mdl-30288995

ABSTRACT

This study investigated the influence of betulinic acid on high-fructose diet-induced metabolic syndrome in rats. Oral administration of betulinic acid significantly reversed high-fructose diet-mediated increase in body mass index and blood glucose. Furthermore, betulinic acid restored high-fructose diet-mediated alterations in metabolic hormones (insulin, leptin and adiponectin). Betulinic acid-mediated upregulation of protein kinase B (Akt) and phosphoinositde-3 kinase (PI3K) anulled high-fructose diet mediated depletion. Also, elevated tumour necrosis factor-α, interleukin-6 and -8 were significantly lowered. Administration of betulinic acid restored high-fructose diet-mediated increase in the levels of lipid profile parameters and indices of atherosclerosis, cardiac and cardiovascular diseases. High-fructose diet-mediated decrease in activities of antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glucose 6-phosphate dehydrogenase) and increase in oxidative stress biomarkers (reduced glutathione, lipid peroxidation products, protein oxidation and fragmented DNA) were significantly restored by the phenolic acids. Conclusively, betulinic acid improves insulin sensitivity, elevated blood glucose, inflammation and dyslipidaemia and oxidative stress in high-fructose diet-induced metabolic syndrome through the PI#Kand Akt pathways .


Subject(s)
Hyperglycemia/drug therapy , Hypoglycemic Agents/pharmacology , Metabolic Syndrome/drug therapy , Phosphatidylinositol 3-Kinases/genetics , Proto-Oncogene Proteins c-akt/genetics , Triterpenes/pharmacology , Animals , Blood Glucose/drug effects , Blood Glucose/metabolism , Catalase/genetics , Catalase/metabolism , Cholesterol/blood , Diet/adverse effects , Fructose/adverse effects , Gene Expression Regulation , Glutathione/genetics , Glutathione/metabolism , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Hyperglycemia/etiology , Hyperglycemia/genetics , Hyperglycemia/metabolism , Insulin/blood , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Metabolic Syndrome/etiology , Metabolic Syndrome/genetics , Metabolic Syndrome/metabolism , Oxidative Stress/drug effects , Pentacyclic Triterpenes , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Rats, Wistar , Signal Transduction , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Triglycerides/blood , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , Betulinic Acid
18.
Int J Biol Macromol ; 145: 226-234, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31866543

ABSTRACT

We, herein, report the effect of chitosan nanofertilizer comprising of copper (Cu) and salicylic acid (SA) on source activity in maize. Seed treatment and foliar application of chitosan nanofertilizer significantly up-regulated the source activity in developing maize plants. Seed treatment with nanofertilizer induced 1.6 folds higher seedling vigour index, 1.7-3.0 folds higher activities of reserve food mobilizing enzymes in seedlings as compared with control. Foliar application of nanofertilizer (0.01-0.16%) statistically significantly increased the activities of antioxidant enzymes (1.06-1.91 folds), reduced malondialdehyde content and enhanced chlorophyll contents (2 folds) in leaves. Application of nanofertilizer remarkably induced sucrose translocation (2.5-3.5 folds) in internodes which gives subtle clue of higher remobilization of nutrients towards growing cob. The elusive bioactivities of nanofertilizer can be attributed to slow release and synergistic effects of Cu and SA. We claim that chitosan nanofertilizer has immense potential to promote source activity in maize for higher crop yield.


Subject(s)
Chitosan/chemistry , Copper/pharmacology , Nanostructures/chemistry , Salicylic Acid/pharmacology , Seedlings/drug effects , Seeds/drug effects , Zea mays/drug effects , Biological Transport/drug effects , Catalase/metabolism , Crops, Agricultural , Fertilizers/analysis , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Nanostructures/ultrastructure , Peroxidase/metabolism , Plant Leaves/drug effects , Plant Leaves/growth & development , Plant Leaves/metabolism , Seedlings/growth & development , Seedlings/metabolism , Seeds/growth & development , Seeds/metabolism , Sucrose/metabolism , Superoxide Dismutase/metabolism , Zea mays/growth & development , Zea mays/metabolism
19.
Bioorg Chem ; 92: 103271, 2019 11.
Article in English | MEDLINE | ID: mdl-31536952

ABSTRACT

A series of fourteen novel thiazolidine-2,4-dione derivatives clubbed with pyrazole moiety were synthesized via four step reaction procedure. Reactions were monitored by thin layer chromatography and were characterized by physicochemical and spectrophotometric (IR, Mass, 1HNMR and 13CNMR) analysis. The spectral data were in good agreement with their structures. The title compounds were docked against peroxisome proliferated activated receptors (PPAR-γ) and alpha-amylase and further evaluated for in vivo and in vitro antidiabetic, in vitro anti-inflammatory and antioxidant activities. Compound GB14 exhibited significant blood glucose lowering activity and was also found to be active inhibitor of alpha-amylase. Compound GB7 was found to be potent anti-inflammatory agent in terms of reducing inflammatory markers (TNF-α, IL-ß, MDA) and also showed antioxidant activity to good extent. Therefore, these compounds may be considered as promising candidates for the development of new antidiabetic agents.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Hypoglycemic Agents/pharmacology , Pyrazoles/pharmacology , Thiazolidinediones/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Blood Glucose/drug effects , Dose-Response Relationship, Drug , Hypoglycemic Agents/chemical synthesis , Hypoglycemic Agents/chemistry , Interleukin-1beta/antagonists & inhibitors , Interleukin-1beta/metabolism , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Mice , Mice, Inbred C57BL , Molecular Docking Simulation , Molecular Structure , PPAR gamma/antagonists & inhibitors , PPAR gamma/metabolism , Pyrazoles/chemistry , Structure-Activity Relationship , Thiazolidinediones/chemistry , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism , alpha-Amylases/antagonists & inhibitors , alpha-Amylases/metabolism
20.
Biochem Biophys Res Commun ; 517(3): 538-544, 2019 09 24.
Article in English | MEDLINE | ID: mdl-31376936

ABSTRACT

Doxorubicin (DOX) is an antitumor drug widely used in hematological tumors and various solid tumors. However, the cardiotoxicity elicited by DOX severely limits its clinical treatment. Dimethyl itaconate (DI), a common form of itaconate, is found many potential targets for prevent heart injury. Here we employed wild type and Nrf2 knockout mice and induced a cardiotoxicity model by administration of DOX to clarify the effects of DI. After treatment with DI, we found that it could effectively alleviate the cardiotoxicity by analyzing morphology, LDH levels and heart weight/body weight ratio changes. Meanwhile we demonstrated that RIP3, a key protein of necrosis, was significantly decreased in DI treated group. Further we observed that treatment with DI could suppress oxidative stress by altering Nrf2/HO-1. Compared with vehicle group, DI could increase the tissue SOD and GSH, and reduce MDA levels, then DHE staining revealed that the level of ROS in DI group reduced by half. Finally, transmission electron microscope (TEM) data showed that treatment with DI obviously decreased the mitochondrial damage. While Nrf2 was ablated in mice, the protective effects of DI were vanished and SOD, GSH, MDA became unchanged related to vehicle group. This report provides the evidence for the protective effects of DI treatment in cardiotoxicity induced by DOX. On mechanisms, DI could reduce the oxidative stress by altering Nrf2/HO-1 pathway and prevent mitochondrial from damage. Taken together, these findings of this paper will afford the new therapeutic targets in DOX related cardiotoxicity.


Subject(s)
Cardiotonic Agents/pharmacology , Cardiotoxicity/prevention & control , Doxorubicin/antagonists & inhibitors , Myocytes, Cardiac/drug effects , NF-E2-Related Factor 2/genetics , Succinates/pharmacology , Acute Disease , Animals , Antibiotics, Antineoplastic/adverse effects , Cardiotoxicity/etiology , Cardiotoxicity/genetics , Cardiotoxicity/pathology , Doxorubicin/adverse effects , Gene Expression , Glutathione/metabolism , Heme Oxygenase-1/genetics , Heme Oxygenase-1/metabolism , Male , Malondialdehyde/antagonists & inhibitors , Malondialdehyde/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/drug effects , Mitochondria/metabolism , Myocardium/metabolism , Myocardium/pathology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , NF-E2-Related Factor 2/deficiency , Oxidative Stress/drug effects , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases/genetics , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...